Russia’s Federal Biomedical Agency on Saturday mentioned it has developed a drug for the treatment of COVID-19.
The company mentioned its drug was based on mefloquine, which is used to stop or deal with malaria.
The drug will allegedly present efficient treatment for COVID-19 sufferers with various severity.
According to the company’s assertion, the drug prevents virus replication in cells and consequently, stops the inflammatory course of attributable to the virus.
Veronika Skvortsova, the company’s head, mentioned Mefloquine needs to be mixed with antibiotics for the utmost impact, permitting a rise within the focus of antiviral brokers in blood plasma and lungs.
“This will guarantee efficient treatment of sufferers with varied levels of Corona Virus an infection,” Skvortsova mentioned.
The company mentioned it was growing an efficient and secure scheme for the prevention of Corona Virus on the premise of mefloquine.
The treatment was developed taking Chinese and French expertise under consideration, it added.
COVID-19 treatment, for now, focuses on relieving signs akin to respiration help.
Companies world wide are racing to develop vaccines. Just a few have launched early security testing in people, however specialists say it may take a 12 months or extra to develop and check a vaccine.